Stockreport

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer [Yahoo! Finance]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF differentiated portfolio spanning immunomodulators, antibody-drug conjugates, mRNA cancer immunotherapies, and their combinations Data updates for pumitamig, a PD-L1xV [Read more]